Trial Details

COMPLETED
Basic Information
Clinical ID c1574
Identifier NCT04458805
Trial Title Safety, Tolerability and Pharmacokinetics of Oral NX-13 in Healthy Adults Male and Female Volunteers
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: NX-13 250 mg|DRUG: Placebo
Participant Information
Sponsor Landos Biopharma Inc.
City Melbourne
Country/Region Australia
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2020-07-10
Primary Completion Date 2020-10-21
Completion Date 2020-10-21